CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins

J Halfvarson1, F Bresso, M D'Amato

  • 1Division of Gastroenterology, Department of Internal Medicine, Orebro University Hospital, 701 85 Orebro, Sweden. jonas.halfvarson@orebroll.se

Insights

Cardiovascular disease (CVD) risk is influenced by genetic factors, including CARD15/NOD2 polymorphisms. These variants are associated with Crohn's disease, a condition with high concordance in monozygotic twins.

Area of Science:

  • Genetics and Molecular Biology
  • Gastroenterology
  • Twin Studies

Background:

  • CARD15/NOD2 polymorphisms are known risk factors for Crohn's disease.
  • Monzygotic twins exhibit high concordance for Crohn's disease and its phenotype.

Purpose of the Study:

  • To investigate the role of CARD15/NOD2 polymorphisms in explaining Crohn's disease concordance in Swedish monozygotic twins.
  • To assess the frequency of specific CARD15/NOD2 variants in concordant and discordant twin pairs.

Main Methods:

  • Study included 29 monozygotic twin pairs with Crohn's disease (9 concordant, 20 discordant) and 192 healthy controls.
  • Genotyping focused on CARD15/NOD2 variants: Arg702Trp, Gly908Arg, and Leu1007fsinsC.

Main Results:

  • CARD15/NOD2 mutations were identified in 13% of affected twins, with a total allele frequency of 6.6%.
  • Only 2 of 9 concordant twin pairs carried CARD15/NOD2 variants; the remaining seven were wild-type.
  • Allele frequency was higher in concordant (11.1%) versus discordant twins (2.5%), though not statistically significant (p=0.06).

Conclusions:

  • CARD15/NOD2 polymorphisms contribute to Crohn's disease concordance in monozygotic twins but do not solely explain it.
  • Other genetic factors are likely involved in Crohn's disease concordance in the Swedish population.
  • The low prevalence of these variants suggests reduced importance in Northern European populations.
Abstract

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...